Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome

Author： Bagley Mark C. Davis Terence Murziani Paola G. S. Widdowson Caroline S. Kipling David

Publisher： MDPI

E-ISSN： 1424-8247|3|6|1842-1872

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.3, Iss.6, 2010-06, pp. : 1842-1872

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts

By Davis Terence Brook Amy J. C. Rokicki Michal J. Bagley Mark C. Kipling David

Pharmaceuticals, Vol. 9, Iss. 2, 2016-04 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy

By Wang Shudong Ding Lijuan Ji Honglei Xu Zheng Liu Quan Zheng Yang

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1037-1037

MDPI

Access to resources Recommend Favorite

BMP9-Induced Survival Effect in Liver Tumor Cells Requires p38MAPK Activation

By García-Álvaro María Addante Annalisa Roncero Cesáreo Fernández Margarita Fabregat Isabel Sánchez Aránzazu Herrera Blanca

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-08 ,pp. : 20431-20448

MDPI

Access to resources Recommend Favorite

Aplysin Sensitizes Cancer Cells to TRAIL by Suppressing P38 MAPK/Survivin Pathway

By Liu Jia Ma Leina Wu Ning Liu Ge Zheng Lanhong Lin Xiukun

Marine Drugs, Vol. 12, Iss. 9, 2014-09 ,pp. : 5072-5088

MDPI

Access to resources Recommend Favorite

A Specific Oligodeoxynucleotide Promotes the Differentiation of Osteoblasts via ERK and p38 MAPK Pathways

By Hou Xu Shen Yuqin Zhang Chao Zhang Liru Qin Yanyan Yu Yongli Wang Liying Sun Xinhua

International Journal of Molecular Sciences, Vol. 13, Iss. 7, 2012-06 ,pp. : 7902-7914

MDPI

Access to resources Recommend Favorite